Abstract: A display device includes a substrate; a transistor disposed on the substrate; a first insulating layer disposed on the transistor; and a first pixel electrode and a second pixel electrode disposed on the first insulating layer to be adjacent to each other. The first insulating layer includes a first opening between the first pixel electrode and the second pixel electrode.

Abstract: Disclosed is a thermal conductivity measuring device including a sample fixing member that fixes a sample, an elastic member that presses the sample fixed to the sample fixing member downwards, and first auxiliary heat emitting part that is spaced apart from the sample fixing member upwards while the elastic member being interposed therebetween.

Abstract: The present invention provides a water-cooled flue gas collecting apparatus disposed in a flow path formed inside a wake treatment structure for cooling and discharging flue gas generated from a test propulsion system. The water-cooled flue gas collecting apparatus includes a gas guiding portion having a flue gas inlet at one end through which the flue gas enters, a gas pipe connected to the flue gas inlet at one end to pass through the other end of the gas guiding portion and form an extension at the other end, and a collecting portion connected to the other end of the gas pipe to collect the flue gas entering through the gas pipe from the flue gas inlet. According to the present invention, the apparatus may be used in rocket propulsion systems of various sizes and allows quantitative analyses.

Abstract: The present invention relates to a seawater flow control device for a uniform motion, and more particularly, to a seawater flow control device for a uniform motion, which controls a velocity of a propulsion system by adjusting a combustion reaction between seawater and a propellant by adjusting a seawater flow rate depending on the number of operating seawater discharge holes. According to the present invention, it is possible to control the velocity of the propulsion system by increasing the amount of seawater when the velocity of the propulsion system is low and decreasing the amount of seawater when the velocity of the propulsion system is high, thereby implementing a uniform motion of the propulsion system.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating solid cancer and blood cancers such as acute leukemia and chronic leukemia, comprising a derivative compound of 1,2-naphthoquinone or a pharmaceutically acceptable salt thereof as an effective component. The derivative compound of 1,2-naphthoquinone is highly effective in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus can be beneficially used as a pharmaceutical composition for preventing or treating cancers, especially solid cancers, acute leukemia, and chronic leukemia.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of solid cancers or blood cancers such as acute leukemia or chronic leukemia, including, as an active ingredient, a 1,2-naphthoquinone derivative compound or a pharmaceutically acceptable salt thereof, wherein the 1,2-naphthoquinone derivative compound has excellent effects in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus, can be useful as a pharmaceutical composition for the prevention or treatment of cancer, in particular, solid cancers, acute leukemia, or chronic leukemia.

Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating solid cancer and blood cancers such as acute leukemia and chronic leukemia, comprising a derivative compound of 1,2-naphthoquinone or a pharmaceutically acceptable salt thereof as an effective component. The derivative compound of 1,2-naphthoquinone is highly effective in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus can be beneficially used as a pharmaceutical composition for preventing or treating cancers, especially solid cancers, acute leukemia, and chronic leukemia.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of solid cancers or blood cancers such as acute leukemia or chronic leukemia, including, as an active ingredient, a 1,2-naphthoquinone derivative compound or a pharmaceutically acceptable salt thereof, wherein the 1,2-naphthoquinone derivative compound has excellent effects in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus, can be useful as a pharmaceutical composition for the prevention or treatment of cancer, in particular, solid cancers, acute leukemia, or chronic leukemia.

Abstract: The proposed technology relates to a thrust control apparatus of a propulsion system, and more particularly, to a thrust control apparatus of a solid propulsion system equipped with an aerospike pintle nozzle. The present invention is to simultaneously control the magnitude and direction of thrust by installing a pintle and a thrust vectoring unit at the rear end of a combustion tube of a solid propulsion system.

Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.

Abstract: Provided is a thrust control apparatus having a plug area variable spike pintle nozzle, in which an aerospike-shaped pintle can be used in a pintle nozzle for precise thrust control. The thrust control apparatus includes a combustion chamber, a motor housing, and an outer pintle nozzle. The motor housing has a driving motor within the combustion chamber. The outer pintle nozzle is moved in a lateral direction by the driving motor.

Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same, for treating a neurodegenerative diseases.

Abstract: The proposed technology relates to a thrust control apparatus of a propulsion system, and more particularly, to a thrust control apparatus of a solid propulsion system equipped with an aerospike pintle nozzle. The present invention is to simultaneously control the magnitude and direction of thrust by installing a pintle and a thrust vectoring unit at the rear end of a combustion tube of a solid propulsion system.

Abstract: A power semiconductor module includes: a substrate including first, second, and third metal patterns separated from each other, a semiconductor element located on the substrate, a lead frame located on the substrate and including first, second, third, and fourth bodies; a first terminal connected to the first body, a second terminal connected to the second body, and a third common terminal that connects the third body and the fourth body, wherein a length of the third common terminal is longer than that of the first and second terminals.

Abstract: A power semiconductor module includes: a substrate including first, second, and third metal patterns separated from each other, a semiconductor element located on the substrate, a lead frame located on the substrate and including first, second, third, and fourth bodies; a first terminal connected to the first body, a second terminal connected to the second body, and a third common terminal that connects the third body and the fourth body, wherein a length of the third common terminal is longer than that of the first and second terminals.

Abstract: A power semiconductor module includes: a substrate including first, second, and third metal patterns separated from each other, a semiconductor element located on the substrate, a lead frame located on the substrate and including first, second, third, and fourth bodies; a first terminal connected to the first body, a second terminal connected to the second body, and a third common terminal that connects the third body and the fourth body, wherein a length of the third common terminal is longer than that of the first and second terminals.

Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.

Abstract: A power semiconductor module includes: a substrate including first, second, and third metal patterns separated from each other, a semiconductor element located on the substrate, a lead frame located on the substrate and including first, second, third, and fourth bodies; a first terminal connected to the first body, a second terminal connected to the second body, and a third common terminal that connects the third body and the fourth body, wherein a length of the third common terminal is longer than that of the first and second terminals.

Abstract: Provided is a method of allocating a stack in a multi-threaded sensor operating system environment. The method dynamically allocates as much stack space as is required by a thread, thereby enabling efficient use of stack space. The method includes the steps of: whenever a function is called while a thread is performing an operation, dynamically allocating a stack space to be used by the called function; and when execution of the function is finished, returning the allocated stack space.